EGR1 and myeloproliferative disorder: Interestingly, haploinsufficiency of EGR1 increased the frequency of myeloproliferative disorder (MPD) and decreased latency in mice treated with a DNA alkylating agent-N-ethyl-nitrosourea (ENU), to induce secondary mutations [26].